Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084160 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nimra Aziz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Rehabilitation, University of Ferrara, via Fossato di Mortara 70, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Lipopolysaccharides, Neuroinflammatory Diseases, Fibroblast Growth Factor 2, Brain-Derived Neurotrophic Factor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Italian Ministry of Health.
Abstract (Originalsprache)
Neuroinflammation is associated with several neurological disorders including temporal lobe epilepsy. Seizures themselves can induce neuroinflammation. In an in vivo model of epilepsy, the supplementation of brain-derived neurotropic factor (BDNF) and fibroblast growth factor-2 (FGF-2) using a Herpes-based vector reduced epileptogenesis-associated neuroinflammation. The aim of this study was to test whether the attenuation of the neuroinflammation obtained in vivo with BDNF and FGF-2 was direct or secondary to other effects, for example, the reduction in the severity and frequency of spontaneous recurrent seizures. An in vitro model of neuroinflammation induced by lipopolysaccharide (LPS, 100 ng/mL) in a mouse primary mixed glial culture was used. The releases of cytokines and NO were analyzed via ELISA and Griess assay, respectively. The effects of LPS and neurotrophic factors on cell viability were determined by performing an MTT assay. BDNF and FGF-2 were tested alone and co-administered. LPS induced a significant increase in pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) and NO. BDNF, FGF-2, and their co-administration did not counteract these LPS effects. Our study suggests that the anti-inflammatory effect of BDNF and FGF-2 in vivo in the epilepsy model was indirect and likely due to a reduction in seizure frequency and severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience and Rehabilitation, University of Ferrara, via Fossato di Mortara 70, 44121 Ferrara, Italy.
- Laboratory of Technologies for Advanced Therapy (LTTA), Technopole of Ferrara, 44121 Ferrara, Italy.
- CNR Institute of Neuroscience, 56124 Pisa, Italy.
- Operating Unit Neurological Clinic, University Hospital of Ferrara, via Aldo Moro 8, 44124 Ferrara, Italy.
- School of Medicine, University Vita-Salute San Raffaele, via Olgettina 58, 20132 Milan, Italy.
- Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy.
ORCID-Profile: Chiara Ruzza, Marie Soukupova, Laila Asth, Valentina Aleotti, Barbara Bettegazzi
Förderung
- European Union
- Italian Ministry of Health
Zitieren
APA
Aziz, N., Ruzza, C., Falcicchia, C., Guarino, A., Soukupova, M., Asth, L., Aleotti, V., Bettegazzi, B., Simonato, M., & Zucchini, S. (2024). Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084160
Vancouver
Aziz N, Ruzza C, Falcicchia C, Guarino A, Soukupova M, Asth L, et al. Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084160
BibTeX
@article{Aziz2024,
author = {Aziz, Nimra and Ruzza, Chiara and Falcicchia, Chiara and Guarino, Annunziata and Soukupova, Marie and Asth, Laila and Aleotti, Valentina and Bettegazzi, Barbara and Simonato, Michele and Zucchini, Silvia},
title = {Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084160}
}
EUVIMED